Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 26.02
+0.84 (3.34%)
Jul 10, 2026, 4:08 PM HKT
Giant Biogene Holding Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Giant Biogene Holding stock has a consensus rating of "Strong Buy" and an average price target of $42.58. The average 1-year stock price forecast is 63.64% higher than the current stock price, while the lowest is $33.40 (+28.36%) and the highest is $82.20 (+215.91%).
Price Target: $42.58 (+63.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Giant Biogene Holding stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 14 | 14 | 14 | 14 | 14 |
| Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Buy Maintains $39.60 | Buy | Maintains | $39.60 | +52.19% | Jun 22, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $49.00 → $40.00 | Buy | Maintains | $49.00 → $40.00 | +53.73% | Jun 19, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +72.94% | Jun 19, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $43.07 | Buy | Maintains | $43.07 | +65.53% | Jun 19, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $37.00 | Buy | Maintains | $37.00 | +42.20% | Jun 17, 2026 |
Financial Forecast
Revenue This Year
6.16B
from 5.52B
Increased by 11.67%
Revenue Next Year
7.02B
from 6.16B
Increased by 13.88%
EPS This Year
2.10
from 2.11
Decreased by -0.27%
EPS Next Year
2.32
from 2.10
Increased by 10.30%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.6B | ||
| Avg | 6.2B | ||
| Low | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 38.4% | ||
| Avg | 11.7% | ||
| Low | 6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.18 | ||
| Avg | 2.10 | ||
| Low | 2.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2% | ||
| Avg | -0.3% | ||
| Low | -3.8% |